Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Clinical trial NCT00061503 · COMPLETED

Trial details

NCT number: NCT00061503
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2003-04-01
Primary completion: 2004-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.